These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 21160370)

  • 1. Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice.
    Miyasaka K; Fujimoto T; Kawanami T; Takiguchi S; Jimi A; Funakoshi A; Shirasawa S
    Pancreas; 2011 Jan; 40(1):79-83. PubMed ID: 21160370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or pancreatic secretion or pancreatic growth: a study in CCK-B receptor gene knockout mice.
    Miyasaka K; Shinozaki H; Suzuki S; Sato Y; Kanai S; Masuda M; Jimi A; Nagata A; Matsui T; Noda T; Kono A; Funakoshi A
    Pancreas; 1999 Aug; 19(2):114-8. PubMed ID: 10438156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism.
    Obourn JD; Frame SR; Chiu T; Solomon TE; Cook JC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):116-26. PubMed ID: 9299603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line.
    Fujimoto T; Koyanagi M; Baba I; Nakabayashi K; Kato N; Sasazuki T; Shirasawa S
    J Hum Genet; 2007; 52(12):978-984. PubMed ID: 17934691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells.
    Inokuchi J; Komiya M; Baba I; Naito S; Sasazuki T; Shirasawa S
    J Hum Genet; 2004; 49(1):46-52. PubMed ID: 14673706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer.
    Fujimoto T; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2413-7. PubMed ID: 21873152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bile acids in gallstone-induced pancreatitis.
    Lerch MM; Aghdassi AA
    Gastroenterology; 2010 Feb; 138(2):429-33. PubMed ID: 20034603
    [No Abstract]   [Full Text] [Related]  

  • 9. The pancreatic and biliary response to hypoglycaemia following both selective and truncal vagotomy.
    McKelvey ST; Kennedy TL; Connell AM
    Br J Surg; 1970 May; 57(5):387. PubMed ID: 5427904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholecystokinin and the mechanism of negative feedback of pancreatic enzyme secretion: animal experiment findings in the rat; possible significance for human physiology].
    Wilms HM
    Z Gastroenterol Verh; 1988 Apr; 23():190-3. PubMed ID: 2454551
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras is essential for the development of the mouse embryo.
    Koera K; Nakamura K; Nakao K; Miyoshi J; Toyoshima K; Hatta T; Otani H; Aiba A; Katsuki M
    Oncogene; 1997 Sep; 15(10):1151-9. PubMed ID: 9294608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
    Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
    Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
    Jin K; Park S; Ewton DZ; Friedman E
    Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J; Jackson RJ; Nicosia SV; Cantor AB; Pledger WJ; Sebti SM
    Oncogene; 2000 Nov; 19(47):5338-47. PubMed ID: 11103935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial functional overlap of the three ras genes in mouse embryonic development.
    Nakamura K; Ichise H; Nakao K; Hatta T; Otani H; Sakagami H; Kondo H; Katsuki M
    Oncogene; 2008 May; 27(21):2961-8. PubMed ID: 18059342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
    Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE
    Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of keratin filament disruption on exocrine pancreas-stimulated secretion and susceptibility to injury.
    Toivola DM; Ku NO; Ghori N; Lowe AW; Michie SA; Omary MB
    Exp Cell Res; 2000 Mar; 255(2):156-70. PubMed ID: 10694432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.